Novo Nordisk, the company that makes the drug, said patient safety was “a top priority” but the study had lots of limitations.
There has been huge hype around semaglutide after celebrities on social media starting posting about their sudden weight loss while taking it.
Despite it being available on prescription only to people with type 2 diabetes (Ozempic) and the most obese (Wegovy), online pharmacies are selling semaglutide injections with few checks on the weight or underlying health of the person buying them.
And as a result, health bosses say they are worried the drug is being misused as “a quick fix” for people trying to get “beach-body ready”.
All medicines carry potential side-effects.
Some of the most common for semaglutide include:
-
nausea
-
vomiting
-
diarrhoea
-
stomach pain
-
constipation
A change in vision is listed as one of the more serious potential side-effects, on both Ozempic and Wegovy’s safety information for patients.
